Early Aldo Blockade in Subclinical PA

NCT07727252 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

880

Enrollment

OTHER

Sponsor class

Conditions

Subclinical Primary Aldosteronism

Interventions

DRUG: Eplerenone
DRUG: Placebo

Sponsor

Xinjiang Medical University